Melola Discovery

← Melola Discovery

Jurnal Tanpa peringkat SINTA

Stem Cell As A Promising Modality In Chronic Kidney Disease Children Future Treatment

Jambi Medical Journal : Jurnal Kedokteran dan Kesehatan · Vol. 13 No. 1 (2025) · hlm. 01–09

DOI
10.22437/jmj.v13i1.29561
ISSN
2580-6874, 2339-269X
Terbit
2025-05-24
Penerbit
FAKULTAS KEDOKTERAN DAN ILMU KESEHATAN UNIVERSITAS JAMBI
Bahasa
en

Abstrak

Background: End-stage kidney disease (ESKD) is the origin of chronic kidney disease (CKD), both in adults and children. The progression of CKD to ESKD often cannot be prevented, even with sophisticated and up-to-date medicines. Method: Data search was conducted by searching for articles in electronic databases, namely PubMed, ScienceDirect, Scopus, Cochrane and Google Scholar. Result: Based on the pathophysiology, the transformation from CKD to ESKD involves a process of fibrosis in the kidneys, which is extensive and persistent. Several studies in experimental animals have found that treatment with stem cells in liver cells can repair cells that have experienced fibrosis, this may be analogous to fibrosis in the kidneys. Through this library extract, we will discuss stem cells, as well as how to treat stem cells for CKD and ESKD in the future. Conclusion: There are various variations in research results on the effectiveness of stem cell therapy in CKD patients. This occurs because of differences in the baseline clinical entity of CKD. Research on stem cell therapy in children has not been well published.

Kata kunci

Jaringan kolaborasi para penulis

3 penulis · 3 tautan kepenulisan bersama · 2 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Padjadjaran University
  • Dr. Hasan Sadikin General Hospital
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Muhammad IlmanPadjadjaran University1
Dedi RachmadiPadjadjaran University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://online-journal.unja.ac.id/index.php/kedokteran/oai, pertama di-harvest 6 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Stem Cell As A Promising Modality In Chronic Kidney Disease Children Future Treatment</dc:title>
	<dc:creator xml:lang="en">Widiasta, Ahmedz</dc:creator>
	<dc:subject xml:lang="en">Chronic Kidney Disease</dc:subject>
	<dc:subject xml:lang="en">Prevention</dc:subject>
	<dc:subject xml:lang="en">Treatment</dc:subject>
	<dc:subject xml:lang="en">Urid Acid Levels</dc:subject>
	<dc:subject xml:lang="en">Stem Cell</dc:subject>
	<dc:description xml:lang="en">Background: End-stage kidney disease (ESKD) is the origin of chronic kidney disease (CKD), both in adults and children. The progression of CKD to ESKD often cannot be prevented, even with sophisticated and up-to-date medicines.
Method: Data search was conducted by searching for articles in electronic databases, namely PubMed, ScienceDirect, Scopus, Cochrane and Google Scholar.
Result: Based on the pathophysiology, the transformation from CKD to ESKD involves a process of fibrosis in the kidneys, which is extensive and persistent. Several studies in experimental animals have found that treatment with stem cells in liver cells can repair cells that have experienced fibrosis, this may be analogous to fibrosis in the kidneys. Through this library extract, we will discuss stem cells, as well as how to treat stem cells for CKD and ESKD in the future.
Conclusion: There are various variations in research results on the effectiveness of stem cell therapy in CKD patients. This occurs because of differences in the baseline clinical entity of CKD. Research on stem cell therapy in children has not been well published.</dc:description>
	<dc:publisher xml:lang="en">FAKULTAS KEDOKTERAN DAN ILMU KESEHATAN UNIVERSITAS JAMBI</dc:publisher>
	<dc:date>2025-05-24</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://online-journal.unja.ac.id/kedokteran/article/view/29561</dc:identifier>
	<dc:identifier>10.22437/jmj.v13i1.29561</dc:identifier>
	<dc:source xml:lang="en">Jambi Medical Journal : Jurnal Kedokteran dan Kesehatan; Vol. 13 No. 1 (2025): JAMBI MEDICAL JOURNAL: Jurnal Kedokteran dan Kesehatan; 01-09</dc:source>
	<dc:source>2580-6874</dc:source>
	<dc:source>2339-269X</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://online-journal.unja.ac.id/kedokteran/article/view/29561/20931</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2025 Jambi Medical Journal : Jurnal Kedokteran dan Kesehatan</dc:rights>
</oai_dc:dc>